Pfizer and Concerto HealthAI partner to develop cancer therapies

Concerto HealthAI (MA, USA) has entered into collaboration with Pfizer (NY, USA), to make use of real-world data and provide actionable patient insights for Pfizer’s investigational therapies and commercialized therapeutics used to treat solid tumors and hematologic malignancies. Concerto HealthAI (MA, USA) will be working with Pfizer (NY, USA) to accelerate patient insights and outcome studies using Concerto’s eurekaHealthâ„¢ platform, artificial intelligence (AI) models and real-world data. The two aim to uncover actionable patient insights faster for Pfizer’s investigational therapies and commercialized therapeutics used in the treatment of solid tumors and hematologic malignancies. Data from clinical practices participating in the...